Live Breaking News & Updates on Arkinson 39 Sdisease

Stay updated with breaking news from Arkinson 39 sdisease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gain Therapeutics Announces Positive Results from the

BETHESDA, Md., April 24, 2024 (GLOBE NEWSWIRE) Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology. ....

Jonas Hannestad , Matthias Alder , Elio Ambrosio , Nic Johnson , Company Annual Report On Form , European Union Horizon , Silverstein Foundation For Parkinson , Exchange Commission On , Michaelj Fox Foundation For Parkinson Research , Swiss Innovation Agency , Exchange Commission , Gain Therapeutics Inc , Bellberry Human Research Ethics Committee , Gain Chief Medical Officer Jonas , Silverstein Foundation , Swiss Innovation , Gain Therapeutics , Site Directed Enzyme Enhancement Therapy , Private Securities Litigation Reform Act , Annual Report , Nasdaq Ganx , Gain Therapeutics , T 02287 , Arkinson 39 Sdisease ,

UPDATE - Gain Therapeutics' GT-02287 Completely Restores

Data presented at 20th WORLDSymposium™ show progressive reversal of motor deficit and corresponding reduction of neurodegeneration biomarker NfL to level. ....

San Diego , United States , Elio Ambrosio , Nic Johnson , Matthias Alder , Gain Therapeutics Inc , Exchange Commission On , Silverstein Foundation For Parkinson , Michaelj Fox Foundation For Parkinson Research , Exchange Commission , Drug Administration , Company Annual Report On Form , Gain Therapeutic Chief Executive , Neurofilament Light Chain , Silverstein Foundation , Gain Therapeutics , Site Directed Enzyme Enhancement Therapy , Private Securities Litigation Reform Act , Annual Report , Nasdaq Ganx , Gain Therapeutics , Arkinson 39 Sdisease ,